KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Non Operating Income (2016 - 2025)

Eli Lilly's Non Operating Income history spans 17 years, with the latest figure at -$108.3 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 1.99% year-over-year to -$108.3 million; the TTM value through Dec 2025 reached -$571.0 million, down 160.73%, while the annual FY2025 figure was -$571.0 million, 160.73% down from the prior year.
  • Non Operating Income reached -$108.3 million in Q4 2025 per LLY's latest filing, up from -$133.1 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $321.1 million in Q1 2021 to a low of -$635.9 million in Q3 2021.
  • Average Non Operating Income over 5 years is -$60.8 million, with a median of -$84.0 million recorded in 2021.
  • Peak YoY movement for Non Operating Income: skyrocketed 436.35% in 2022, then tumbled 981.92% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$77.3 million in 2021, then surged by 436.35% to $260.0 million in 2022, then plummeted by 53.35% to $121.3 million in 2023, then tumbled by 191.1% to -$110.5 million in 2024, then increased by 1.99% to -$108.3 million in 2025.
  • Per Business Quant, the three most recent readings for LLY's Non Operating Income are -$108.3 million (Q4 2025), -$133.1 million (Q3 2025), and -$90.6 million (Q2 2025).